echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > New research: heat-resistant new crown vaccine formula is effective against mutant strains

    New research: heat-resistant new crown vaccine formula is effective against mutant strains

    • Last Update: 2021-07-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    New research: heat-resistant new crown vaccine formula is effective against mutant strains
    New research: The heat-resistant new crown vaccine formulation is effective against mutant strains New research: The heat-resistant new crown vaccine formulation is effective against mutant strains

    Xinhua News Agency, Canberra, July 16 (Reporter Yue Dongxing and Bai Xu) An international research team recently published a research report in the American Journal of Infectious Diseases.
    Effectively fight against COVID-19 mutant strains
    .

    Researchers from the Commonwealth Scientific and Industrial Research Organization of Australia and the Indian Institute of Science have jointly designed a heat-resistant trimerized novel coronavirus receptor binding domain derivative
    .


    Animal experiments have shown that this new vaccine formula triggers a strong immune response in experimental mice, which can protect them from the new coronavirus infection, and the antibodies induced by the formula can also neutralize 4 mutant strains such as Delta and Alpha


    Researchers said that most of the new crown vaccines need to be refrigerated to maintain their effectiveness.
    For example, AstraZeneca vaccines need to be stored at 2 to 8 degrees Celsius, while Pfizer vaccines need to be specifically refrigerated at minus 70 degrees Celsius
    .


    The new vaccine formula is heat-resistant and can be used in remote and high-temperature areas where the cold chain conditions of the vaccine cannot be provided


    Next, the researchers will also prepare for the clinical trial of the formula vaccine, which is expected to be carried out in India later this year


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.